A 47-year-old man had surgery for paraaortic paraganglioma in 1980 and 1985. In 1987, his urinary excretion of catecholamines and metabolites was extremely high. Scintigraphy with 131I-metaiodobenzylguanidine (MIBG) showed multiple bone and liver metastases. He was treated twice with infusions of 3.7 GBq of 131I-MIBG. After the first treatment, he had transient hypertension and pain in the back and right leg. Subsequent 131I-MIBG scintigraphy showed that the number of metastatic tumors had decreased. The second treatment was less effective. Excess catecholamines were treated with alpha-methyl-p-tyrosine (MPT), a catecholamine synthesis inhibitor, at doses between 250 and 2000 mg/day, which significantly decreased urinary NE excretion. This is the first case treated with 131I-MIBG in Japan. © 1990, The Japanese Society of Internal Medicine. All rights reserved.
CITATION STYLE
Nakagami, Y., Nomura, K., Miko, N., Tsushima, T., Demura, H., & Kusakabe, K. (1990). A Case of Malignant Pheochromocytoma Treated with 131I-Metaiodobenzylguanidine and Alpha-Methyl-p-Tyrosine. Japanese Journal of Medicine, 29(3), 329–333. https://doi.org/10.2169/internalmedicine1962.29.329
Mendeley helps you to discover research relevant for your work.